Anixa Biosciences Inc (ANIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 01-2016 | 10-2015 | 07-2015 | 04-2015 | 01-2015 | |
| Sales | 0 | 0 | 95 | 25 | 9,135 |
| Gross Profit | N/A | N/A | 95 | 25 | 9,135 |
| Operating Expenses | 1,472 | 1,178 | 1,586 | 2,158 | 5,278 |
| Operating Income | -1,472 | -1,178 | -1,491 | -2,133 | 3,857 |
| Interest Expense | 124 | 118 | 116 | 109 | 109 |
| Other Income | 3 | 3 | 5 | 5 | 5 |
| Pre-tax Income | -1,593 | -1,292 | -1,602 | -2,237 | 3,752 |
| Net Income Continuous | -1,593 | -1,292 | -1,602 | -2,237 | 3,752 |
| Net Income | $-1,593 | $-1,292 | $-1,602 | $-2,237 | $3,752 |
| EPS Basic Total Ops | -0.18 | -0.15 | -0.18 | -0.26 | 0.43 |
| EPS Basic Continuous Ops | -0.18 | -0.15 | -0.18 | -0.26 | 0.43 |
| EPS Diluted Total Ops | -0.18 | -0.13 | -0.18 | -0.26 | 0.41 |
| EPS Diluted Continuous Ops | -0.18 | -0.13 | -0.18 | -0.26 | 0.41 |
| EBITDA(a) | $-1,263 | $-966 | $-1,293 | $-1,944 | $4,048 |